WallStreetZenWallStreetZen

NYSE: EW
Edwards Lifesciences Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Edwards Lifesciences earnings were $1.1B for the trailing 12 months ending Dec 31, 2025, with -73.6% growth year over year. The latest EW earnings report on Dec 31, 2025 announced Q4 2025 earnings of $91.2M, down 68.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EW reported annual earnings of $1.1B, with -74.3% growth.

EW past earnings growth

How has EW's earnings growth performed historically?

Company
-73.64%
Industry
28.73%
Market
90.64%
EW's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
EW's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
EW's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

EW earnings history

Current Revenue
$6.1B
Current Earnings
$1.1B
Current Profit Margin
17.7%
EW's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

EW Return on Equity

Current Company
10.4%
Current Industry
8.8%
Current Market
28.9%
EW's Return on Equity (10.4%)... subscribe to Premium to read more.
High Return on Equity Performance

EW Return on Assets

Current Company
8%
Current Industry
5.4%
EW is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EW announces earnings.

EW Return on Capital Employed

Current Company
11.03%
Current Industry
9.4%
EW's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EW vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EW$1.49B$1.07B+6.87%$1.84
PHG$3.12B$1.05BN/A-$0.88
DXCM$1.48B$930.40M+9.18%$2.40
STE$1.48B$707.87M+7.18%$7.20
ZBH$2.31B$761.10M+7.15%$3.87
View Top Medical Device Stocks

Edwards Lifesciences Earnings Reports & History FAQ

What were Edwards Lifesciences's earnings last quarter?

On EW's earnings call on Invalid Date, Edwards Lifesciences (NYSE: EW) reported Q4 2025 earnings per share (EPS) of $0.16, up 76.12% year over year. Total EW earnings for the quarter were $91.20 million. In the same quarter last year, Edwards Lifesciences's earnings per share (EPS) was $0.67.

If you're new to stock investing, here's how to buy Edwards Lifesciences stock.

Is Edwards Lifesciences profitable or losing money?

As of the last Edwards Lifesciences earnings report, Edwards Lifesciences is currently profitable. Edwards Lifesciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $1.07 billion, a 74.28% decrease year over year.

What was EW's earnings growth in the past year?

As of Edwards Lifesciences's earnings date in Invalid Date, Edwards Lifesciences's earnings has grown -73.64% year over year. This is 102.37 percentage points lower than the US Medical Devices industry earnings growth rate of 28.73%. EW earnings in the past year totalled $1.07 billion.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.